LAZARD ASSET MANAGEMENT LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is and the CUSIP is 452907AK4. A total of 5 filers reported holding IMMUNOMEDICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2017$29,320,000
+59.7%
16,000,000
+23.1%
0.06%
+57.1%
Q1 2017$18,354,00013,000,0000.04%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
DLD Asset Management, LP 10,000,000$18,404,0002.40%
Castle Creek Arbitrage, LLC 5,512,000$10,097,0001.08%
Orbimed Advisors 30,000,000$54,794,0000.57%
Graham Capital Management, L.P. 7,000,000$12,833,0000.34%
WOLVERINE ASSET MANAGEMENT LLC 10,010,000$18,308,0000.23%
LAZARD ASSET MANAGEMENT LLC 16,000,000$29,320,0000.06%
Jefferies Group LLC 3,889,000$7,100,0000.05%
PALISADE CAPITAL MANAGEMENT, LP 535,000$982,0000.04%
Paloma Partners Management Co 1,500,000$2,744,0000.03%
Citadel Advisors 12,990,000$23,907,0000.02%
View complete list of IMMUNOMEDICS INC shareholders